Concentrix Q2 2024 Adj EPS $2.69 Beats $2.62 Estimate, Sales $2.380B Beat $2.348B Estimate
Portfolio Pulse from Benzinga Newsdesk
Concentrix (NASDAQ:CNXC) reported Q2 2024 adjusted EPS of $2.69, beating the estimate of $2.62. Sales were $2.380 billion, surpassing the $2.348 billion estimate and marking a 47.37% increase from the same period last year.
June 26, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Concentrix reported strong Q2 2024 results with EPS and sales beating estimates. Sales increased by 47.37% YoY, indicating robust growth.
The strong earnings and revenue beat, along with significant year-over-year growth, are likely to positively impact CNXC's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100